HIGHLIGHTS
- who: Valerie Wittibschlager and colleagues from the Department of Medical Oncology, Inselspital, University Hospital of Bern, Bern, Switzerland have published the paper: CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma, in the Journal: (JOURNAL) of 12/02/2023
- what: From the study show that CAR T-cell persistence at 6 months correlates with improved clinical outcome in patients with B-cell lymphomas.
- how: The authors conducted a single-center retrospective observational study analyzing data from r/r B-cell lymphoma patients treated with CAR T-cell therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.